日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers

利伐沙班与低剂量阿司匹林在 2 型糖尿病和高心血管风险患者中的比较:一项评估对内皮功能、血小板活化和血管生物标志物影响的随机试验

Frank Pistrosch, Jan B Matschke, Dorothea Schipp, Bernhard Schipp, Elena Henkel, Ingo Weigmann, Jan Sradnick, Stefan R Bornstein, Andreas L Birkenfeld, Markolf Hanefeld

Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of pioglitazone, metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study

双盲、随机、多中心、主动对照研究,探讨吡格列酮、二甲双胍及二者合用对接受稳定基础胰岛素治疗的 2 型糖尿病患者心血管风险的影响:PIOCOMB 研究

Markolf Hanefeld, Andreas Pfützner, Thomas Forst, Iris Kleine, Winfried Fuchs